Abvc Biopharma (ABVC) Long-Term Investments (2018 - 2026)
Abvc Biopharma (ABVC) reported Long-Term Investments of $2.49 million for Q2 2026, down 12.3% from $2.84 million a year earlier but up 34.9% from the prior quarter.
Abvc Biopharma (ABVC) Long-Term Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma posted Long-Term Investments of $1.88 million, down 16.8% from FY2024.
- Long-Term Investments has a five-year compound annual growth rate of 9.5% (FY2020 to FY2025).
- By year, Long-Term Investments came in at $2.26 million in FY2024 (-10.6%), $2.53 million in FY2023 (+200.2%), $842,070 in FY2022 (-9.7%) and $932,755 in FY2021 (-21.7%).
- Five-year quarterly Long-Term Investments spans a low of $816,160 in Q3 2022 and a high of $2.84 million in Q2 2025.
- Year over year, Long-Term Investments has now declined in each of the last three quarters, with an average decline of 4.6% over the last eight quarters.
- The high point for year-over-year Long-Term Investments in five years was Q3 2023 (growth of 228.0%); the low point was Q1 2026 (a decline of 33.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.85 million (Q1 2026), $1.88 million (Q4 2025) and $2.75 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | 2.49 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Mn |
| Mar 31, 2026 | 1.85 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 2.75 Mn |
| Jun 30, 2025 | 2.84 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Dec 31, 2024 | 2.26 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 2.47 Mn |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 2.68 Mn |
| Jun 30, 2023 | 831,706.00 |
| Mar 31, 2023 | 849,843.00 |
| Dec 31, 2022 | 842,070.00 |
| Sep 30, 2022 | 816,160.00 |
| Jun 30, 2022 | 870,571.00 |
| Mar 31, 2022 | 904,254.00 |
| Dec 31, 2021 | 932,755.00 |
| Sep 30, 2021 | 1.01 Mn |
Abvc Biopharma Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();